Sirona Biochem Corp (SBM) - Total Liabilities

Latest as of July 2024: CA$4.27 Million CAD ≈ $3.09 Million USD

Based on the latest financial reports, Sirona Biochem Corp (SBM) has total liabilities worth CA$4.27 Million CAD (≈ $3.09 Million USD) as of July 2024. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Sirona Biochem Corp - Total Liabilities Trend (2011–2023)

This chart illustrates how Sirona Biochem Corp's total liabilities have evolved over time, based on quarterly financial data. See SBM working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Sirona Biochem Corp Competitors by Total Liabilities

The table below lists competitors of Sirona Biochem Corp ranked by their total liabilities.

Company	Country	Total Liabilities
Huize Holding Ltd NASDAQ:HUIZ	USA	$472.74 Million
Guideline Geo AB (publ) ST:GGEO	Sweden	Skr34.35 Million
Sadbhav Infrastructure Project Limited NSE:SADBHIN	India	Rs56.20 Billion
Mustika Ratu Tbk JK:MRAT	Indonesia	Rp243.08 Billion
InnSuites Hospitality Trust NYSE MKT:IHT	USA	$14.04 Million
Megalestari Epack Sentosaraya Pt JK:EPAC	Indonesia	Rp184.47 Billion
Gurktaler Aktiengesellschaft VI:GAGV	Austria	€568.00K
AUGA GROUP AB EO 029 F:W9Z	Germany	€172.99 Million

Liability Composition Analysis (2011–2023)

This chart breaks down Sirona Biochem Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Sirona Biochem Corp stock valuation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.34	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-1.23	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	5.28	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Sirona Biochem Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Sirona Biochem Corp (2011–2023)

The table below shows the annual total liabilities of Sirona Biochem Corp from 2011 to 2023.

Year	Total Liabilities	Change
2023-10-31	CA$3.54 Million ≈ $2.56 Million	+229.26%
2022-10-31	CA$1.08 Million ≈ $778.50K	-22.27%
2021-10-31	CA$1.38 Million ≈ $1.00 Million	-33.75%
2020-10-31	CA$2.09 Million ≈ $1.51 Million	+1.09%
2019-10-31	CA$2.07 Million ≈ $1.50 Million	-31.80%
2018-10-31	CA$3.03 Million ≈ $2.19 Million	-7.90%
2017-10-31	CA$3.29 Million ≈ $2.38 Million	+110.75%
2016-10-31	CA$1.56 Million ≈ $1.13 Million	-21.95%
2015-10-31	CA$2.00 Million ≈ $1.45 Million	+22.20%
2014-10-31	CA$1.64 Million ≈ $1.18 Million	+36.84%
2013-10-31	CA$1.20 Million ≈ $865.73K	+22.51%
2012-10-31	CA$976.91K ≈ $706.69K	+33.42%
2011-10-31	CA$732.20K ≈ $529.66K	--

About Sirona Biochem Corp

V:SBM Canada Biotechnology

Market Cap

$11.23 Million

CA$15.53 Million CAD

Market Cap Rank

#26758 Global

#1115 in Canada

Share Price

CA$0.06

Change (1 day)

+0.00%

52-Week Range

CA$0.06 - CA$0.06

All Time High

CA$0.66